ArticleTherapeutic advances in medical oncology2024

Current evidence of PD-1 and PD-L1 immune checkpoint inhibitors for esophageal cancer: an updated meta-analysis and synthesis of ongoing clinical trials.

Saram Zafar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.